Capricor Therapeutics

CAPRNasdaq United States Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$236.860 M

$4.09 -2.15%

Close of 7 Aug 2026

Revenue

$0.00

#3658 by revenue

Earnings

-$105.0M

Loss-making

Shares outstanding

57,510,635

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations — ranked by market cap

All 501 →

#256AC ImmuneACIU$240.2M
#257OrganogenesisORGO$239.3M
#258Capricor TherapeuticsCAPR$236.9M
#259Pyxis OncologyPYXS$236.3M
#260Keros TherapeuticsKROS$221.1M

Where these numbers come from

Share counts and financials for Capricor Therapeutics are taken from its own SEC filings via EDGAR — public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 9 Aug 2026. Read the methodology.